DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) General Information
Description
A number of drug product candidates' rights are intended to be used for the treatment of opiate addiction and alcohol abuse. The drugs work as an antagonist that blocks receptors in the brain and to be taken once-a-month intramuscular injection.
Contact Information
Corporate Office
- 1430 Obrien Drive
- Suite E
- Menlo Park, CA 94025
- United States
Corporate Office
- 1430 Obrien Drive
- Suite E
- Menlo Park, CA 94025
- United States
DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) FAQs
-
Where is DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) headquartered?
DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) is headquartered in Menlo Park, CA.
-
What industry is DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) in?
DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights)’s primary industry is Buildings and Property.
-
Is DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) a private or public company?
DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) is a Private company.
-
What is DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights)’s current revenue?
The current revenue for DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) is .
-
Who are DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights)’s investors?
DrugAbuse Sciences has invested in DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights).
-
When was DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) acquired?
DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) was acquired on 19-Jan-2007.
-
Who acquired DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights)?
DrugAbuse Sciences (Late-Stage Drug Candidate and Product Rights) was acquired by Elbion.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process